Anadin

Anadin is a consumer-health brand of over-the-counter pain medicines sold primarily in the United Kingdom and Ireland. The brand was introduced in the United Kingdom in 1932 by Anacin, an American pharmaceutical company, and has since developed into a long-standing name in British pharmacy and general retail. Its products have been marketed for common short-term pain conditions including headaches, migraine, back pain and joint pain. The Anadin portfolio has included both single-ingredient and combination medicines. Anadin Original is an aspirin-and-caffeine formulation, while Anadin Extra combines aspirin, paracetamol and caffeine. The range has also included paracetamol tablets, ibuprofen tablets, joint-pain products and ibuprofen liquid capsules sold under names such as Anadin Liquifast or Anadin Ultra. Product availability, formulation, pack size and regulatory status can vary over time and by market; the brand name alone should not be treated as an indication of a product's active ingredients. Several important additions were made during the brand's development. Anadin Extra was introduced in an ordinary tablet format in 1983 and later offered in a soluble form in 1992. Anadin paracetamol tablets followed in 1988, and Anadin ibuprofen tablets were introduced in 1997. These extensions broadened the brand beyond its original aspirin-and-caffeine positioning and allowed it to address different consumer preferences and pain occasions. Anadin occupies the everyday analgesics segment, competing with other branded medicines as well as pharmacy and supermarket own-label equivalents. Its combination products have historically been differentiated by the inclusion of caffeine and, in some formulations, more than one analgesic active ingredient. Such combinations can have different warnings, contraindications and suitability requirements from single-ingredient products. Consumers therefore need to follow the instructions and warnings for the specific pack, particularly concerning aspirin, paracetamol, ibuprofen, age restrictions, pregnancy, gastrointestinal conditions and the risk of taking overlapping medicines. The brand is currently associated with Haleon, the consumer-health company formed through the separation of GSK's consumer-health business. Publicly available reference material establishes Anadin's launch year, principal product history and ownership context, but does not provide a complete account of every formulation change, advertising campaign, executive decision or current distribution arrangement. Anadin remains best understood as a UK-focused analgesic brand rather than as a pharmaceutical company in its own right.

Anadin's documented history begins in 1932, when the brand was launched in the United Kingdom by Anacin, an American pharmaceutical company. Its introduction created a UK-market identity for a painkiller brand that had originated in the United States. Anadin subsequently became established in the British and Irish over-the-counter medicines market, where it has been sold through pharmacy and general retail channels. The brand's early identity was associated with aspirin-based pain relief. Over time, its portfolio expanded into products using different active ingredients and combinations. Anadin Extra was introduced as an ordinary tablet in 1983, combining aspirin, paracetamol and caffeine. A soluble version followed in 1992, extending the range into a format intended to dissolve before use. These products gave the brand a broader proposition than a single aspirin-based medicine while retaining its established combination-analgesic identity. Anadin added paracetamol tablets in 1988 and ibuprofen tablets in 1997. The expansion reflected the major categories of non-prescription analgesics available to consumers and enabled the brand to offer alternatives to aspirin-based products. Other products documented in the range include Anadin Original, based on aspirin and caffeine; Anadin Joint Pain; and ibuprofen liquid capsules sold as Anadin Liquifast or Anadin Ultra, including standard and double-strength versions. Product ranges and formulations are not necessarily permanent, and historical listings should not be assumed to represent the complete current portfolio. Anadin's market position has also been shaped by the economics of branded medicines. In 2008, the brand was among the analgesic names criticised for charging a premium over generic equivalents. A reported comparison contrasted the price of a 16-tablet pack of Anadin paracetamol with the much lower retail price of an unbranded pack containing the same stated strength of paracetamol. The criticism concerned price positioning rather than an allegation that the medicine was unsafe or ineffective. Ownership of the brand has changed as consumer-health businesses have been reorganised. The available reference material identifies Haleon as Anadin's current owner. Haleon is a consumer-health company whose portfolio includes non-prescription medicines and other self-care products. The accessible public record does not establish a detailed chronology of earlier corporate transactions, brand managers, advertising campaigns or every regulatory change affecting Anadin. Accordingly, the most defensible account of the brand's history is a chronology of its documented UK launch, product extensions, pricing criticism and present association with Haleon.

• 2008

  Branded-versus-generic pricing criticism

  [1]Anadinen.wikipedia.org

  Anadin paracetamol was cited in criticism of the price premium charged by branded analgesics over generic equivalents.

• 1997

  Ibuprofen range added

  [1]Anadinen.wikipedia.org

  Anadin ibuprofen tablets were launched, broadening the brand's active-ingredient offering.

• 1992

  Soluble Anadin Extra introduced

  [1]Anadinen.wikipedia.org

  A soluble version of Anadin Extra was added to the range.

• 1988

  Paracetamol range added

  [1]Anadinen.wikipedia.org

  Anadin paracetamol tablets were launched, expanding the portfolio beyond its earlier aspirin-based products.

• 1983

  Anadin Extra introduced

  [1]Anadinen.wikipedia.org

  The original Anadin Extra tablet, containing aspirin, paracetamol and caffeine, was introduced.

• 1932

  UK launch

  [1]Anadinen.wikipedia.org

  Anadin was launched in the United Kingdom by Anacin, an American pharmaceutical company.

A familiar United Kingdom and Ireland over-the-counter analgesic brand for convenient relief of common everyday pain.

• Aspirin-and-caffeine analgesic

  Anadin Original

  Anadin Original is the brand's aspirin-and-caffeine painkiller formulation. It represents the traditional combination-analgesic side of the portfolio and has been marketed for common short-term pain relief. The exact directions, strength, pack presentation and availability should be verified against the relevant product packaging and current UK medicine information.

• Combination analgesic · 1983

  Anadin Extra

  Anadin Extra combines aspirin, paracetamol and caffeine. The ordinary tablet version was introduced in 1983 and a soluble version followed in 1992. Because it contains multiple active ingredients, users need to follow the product-specific warnings and avoid duplicating paracetamol or other analgesics through additional medicines.

• Paracetamol analgesic · 1988

  Anadin paracetamol tablets

  Anadin paracetamol tablets were added to the portfolio in 1988. They provide a single-ingredient alternative within the brand's range and have been positioned for ordinary pain-relief needs. Strength, dosage instructions and current availability must be checked on the specific pack, particularly because excessive total paracetamol intake can cause serious harm.

• Ibuprofen analgesic · 1997

  Anadin ibuprofen tablets

  Anadin ibuprofen tablets were launched in 1997. The product extended the brand into the ibuprofen segment and offered a non-aspirin option within the historical range. Ibuprofen has its own contraindications and interaction warnings, so the relevant formulation, age guidance and precautions should be reviewed before use.

• Pain-relief medicine

  Anadin Joint Pain

  Anadin Joint Pain is a product name used within the brand's documented range for medicines aimed at joint-pain occasions. Publicly available reference material does not provide enough detail to establish a complete formulation history or current market status, so the active ingredient and instructions should be confirmed from the product's current packaging.

• Ibuprofen liquid capsules

  Anadin Liquifast / Anadin Ultra

  Anadin Liquifast, also referred to as Anadin Ultra in the documented range, consists of ibuprofen-based liquid capsules. The range has included ordinary and double-strength versions. As with other ibuprofen products, the formulation, strength and suitability depend on the particular pack and the user's health circumstances.

• 1997

  Addition of ibuprofen tabletsProduct launch

  Background

  The brand extended its range into another major over-the-counter analgesic ingredient.

  Action taken

  Anadin launched ibuprofen tablets.

  Aftermath

  Ibuprofen became part of the brand's documented product architecture alongside aspirin and paracetamol products.

  Source

• 1988

  Addition of paracetamol tabletsProduct launch

  Background

  Anadin broadened its analgesic range to include a single-ingredient paracetamol product.

  Action taken

  The brand launched Anadin paracetamol tablets.

  Aftermath

  The portfolio covered both combination medicines and a paracetamol-only option.

  Source

• 1983

  Launch of Anadin ExtraProduct launch

  Background

  The brand expanded its combination-analgesic offering beyond its earlier aspirin-and-caffeine identity.

  Action taken

  Anadin introduced a tablet combining aspirin, paracetamol and caffeine.

  Aftermath

  The product became one of the documented core formulations in the Anadin range.

  Source

1. 1Anadinen.wikipedia.org